There were 1,862 press releases posted in the last 24 hours and 400,179 in the last 365 days.

Immucor to Host Debt Investor Conference Call on Tuesday, February 7, 2017

NORCROSS, Ga., Jan. 17, 2017 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt investors on Tuesday, February 7, 2017 at 2:00 p.m. ET to discuss its fiscal 2017 second quarter results.

Interested debt investors and analysts should contact Immucor Investor Relations at investor-requests@immucor.com or 770-441-2051 for details.

About Immucor 
Founded in 1982, Immucor is a global leader in transfusion and transplantation diagnostics that facilitate patient-donor compatibility. Our mission is to ensure that patients in need of blood, organs or stem cells get the right match that is safe, accessible and affordable. With the right match, we can transform a life together. For more information on Immucor, please visit our website at www.immucor.com.

Michele Howard
770-441-2051

Primary Logo